Novel anti-cholesterol monoclonal immunoglobulin G antibodies as probes and potential modulators of membrane raft-dependent immune functions

被引:26
作者
Biro, Adrienn
Cervenak, Laszlo
Balogh, Andrea
Lorincz, Andras
Uray, Katalin
Horvath, Anna
Romics, Laszlo
Matko, Janos
Furst, George
Laszlo, Gloria [1 ]
机构
[1] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary
[2] Eotvos Lorand Univ, Dept Organ Chem, Budapest, Hungary
[3] Semmelweis Univ, Dept Internal Med 3, Res Lab, H-1085 Budapest, Hungary
[4] Semmelweis Univ, Hungarian Acad Sci, Res Grp Metab & Atherosclerosis, H-1085 Budapest, Hungary
关键词
membrane cholesterol; lymphocytes; monocyte-macrophage cells; lipoproteins; lipid rafts; caveolae;
D O I
10.1194/jlr.M600158-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
l Natural autoantibodies against cholesterol are present in the sera of all healthy individuals; their function, production, and regulation, however, are still unclear. Here, we managed to produce two monoclonal anti-cholesterol antibodies (ACHAs) by immunizing mice with cholesterol-rich liposomes. The new ACHAs were specific to cholesterol and to some structurally closely related 3 beta-hydroxyl sterols, and they reacted with human lipoproteins VLDL, LDL, and HDL. They bound, usually with low avidity, to live human or murine lymphocyte and monocyte-macrophage cell lines, which was enhanced substantially by a moderate papain digestion of the cell surface, removing some protruding extracellular protein domains. Cell-bound ACHAs strongly colocalized with markers of cholesterol-rich lipid rafts and caveolae at the cell surface and intracellularly with markers of the endoplasmic reticulum and Golgi complex. These data suggest that these IgG ACHAs may serve as probes of clustered cholesterol (e. g., different lipid rafts) in live cells and thus may also have immunomodulatory potential.
引用
收藏
页码:19 / 29
页数:11
相关论文
共 39 条
[1]  
Alonso MA, 2001, J CELL SCI, V114, P3957
[2]   Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation [J].
Alving, CR ;
Swartz, GM ;
Wassef, NM ;
Ribas, JL ;
Herderick, EE ;
Virmani, R ;
Kolodgie, FD ;
Matyas, GR ;
Cornhill, JF .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 127 (01) :40-49
[3]   NATURALLY-OCCURRING AUTOANTIBODIES TO CHOLESTEROL IN HUMANS [J].
ALVING, CR ;
SWARTZ, GM ;
WASSEF, NM .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (04) :637-639
[4]   Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism [J].
Alving, CR ;
Wassef, NM .
IMMUNOLOGY TODAY, 1999, 20 (08) :362-366
[5]  
ALVING CR, 1995, CURR TOP MICROBIOL I, V210, P181
[6]   Fluorescence correlation spectroscopy relates rafts in model and native membranes [J].
Bacia, K ;
Scherfeld, D ;
Kahya, N ;
Schwille, P .
BIOPHYSICAL JOURNAL, 2004, 87 (02) :1034-1043
[7]  
BALOGH A, 2006, 16 EUR C IMM PAR FRA
[8]   Dramatic changes in the serum levels of anti-cholesterol antibodies after eversion endarterectomy in patients with severe carotid atherosclerosis [J].
Bíró, A ;
Dósa, E ;
Horváth, A ;
Prohászka, Z ;
Rugonfalvi-Kiss, S ;
Szabó, A ;
Karádi, I ;
Acsády, G ;
Selmeczi, L ;
Entz, L ;
Füst, G ;
Romics, L .
IMMUNOLOGY LETTERS, 2005, 99 (01) :51-56
[9]   Serum anti-cholesterol antibodies in chronic hepatitis-C patients during IFN-α-2b treatment [J].
Bíró, A ;
Horváth, A ;
Varga, L ;
Nemesánszky, E ;
Csepregi, A ;
Dávid, K ;
Tolvaj, G ;
Ibrányi, E ;
Telegdy, L ;
Pár, A ;
Romics, L ;
Karádi, I ;
Horányi, M ;
Gervain, J ;
Ribiczey, P ;
Csöndes, M ;
Füst, G .
IMMUNOBIOLOGY, 2003, 207 (03) :161-168
[10]  
Dijkstra J, 1996, J IMMUNOL, V157, P2006